170 related articles for article (PubMed ID: 36930972)
21. Intravenous lipid emulsions and liver function in adult chronic intestinal failure patients: Results after 5 y of home parenteral nutrition.
Klek S; Szczepanek K; Scislo L; Walewska E; Pietka M; Pisarska M; Pedziwiatr M
Nutrition; 2021 Feb; 82():111029. PubMed ID: 33221116
[TBL] [Abstract][Full Text] [Related]
22. Trends in liver profile and nutrition outcomes in children undergoing intestinal rehabilitation using a mixed lipid injectable emulsion.
Wassef J; Lipkin E; Hardigan P; Duro D
Nutr Clin Pract; 2022 Oct; 37(5):1180-1189. PubMed ID: 34618376
[TBL] [Abstract][Full Text] [Related]
23. Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure.
Rochling FA
Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801970
[TBL] [Abstract][Full Text] [Related]
24. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.
Nandivada P; Baker MA; Mitchell PD; O'Loughlin AA; Potemkin AK; Anez-Bustillos L; Carlson SJ; Dao DT; Fell GL; Gura KM; Puder M
Am J Clin Nutr; 2016 Sep; 104(3):663-70. PubMed ID: 27510535
[TBL] [Abstract][Full Text] [Related]
25. Pediatric intestinal failure-associated liver disease is reversed with 6 months of intravenous fish oil.
Calkins KL; Dunn JC; Shew SB; Reyen L; Farmer DG; Devaskar SU; Venick RS
JPEN J Parenter Enteral Nutr; 2014 Aug; 38(6):682-92. PubMed ID: 23894176
[TBL] [Abstract][Full Text] [Related]
26. SMOFlipid vs Intralipid 20%: Effect of Mixed-Oil vs Soybean-Oil Emulsion on Parenteral Nutrition-Associated Cholestasis in the Neonatal Population.
Jackson RL; White PZ; Zalla J
JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):339-346. PubMed ID: 32391595
[TBL] [Abstract][Full Text] [Related]
27. Growth in Infants and Children With Intestinal Failure-associated Liver Disease Treated With Intravenous Fish Oil.
Raphael BP; Mitchell PD; Gura KM; Potemkin AK; Squires RH; Puder M; Duggan CP
J Pediatr Gastroenterol Nutr; 2020 Feb; 70(2):261-268. PubMed ID: 31978030
[TBL] [Abstract][Full Text] [Related]
28. Clinical application of fish-oil intravenous lipid emulsion in adult home parenteral nutrition patients.
Mundi MS; Bonnes SL; Salonen BR; McMahon MM; Martindale R; Hurt RT
Nutr Clin Pract; 2021 Aug; 36(4):839-852. PubMed ID: 32970359
[TBL] [Abstract][Full Text] [Related]
29. Reversal of Intestinal Failure-Associated Liver Disease by Increasing Fish Oil in a Multi-Oil Intravenous Lipid Emulsion in Adult Short Bowel-Syndrome Patients.
Park HJ; Lee S; Park CM; Yoo K; Seo JM
JPEN J Parenter Enteral Nutr; 2021 Jan; 45(1):204-207. PubMed ID: 32181905
[TBL] [Abstract][Full Text] [Related]
30. Some new insights in intestinal failure-associated liver disease.
Goulet O; Joly F; Corriol O; Colomb-Jung V
Curr Opin Organ Transplant; 2009 Jun; 14(3):256-61. PubMed ID: 19444108
[TBL] [Abstract][Full Text] [Related]
31. Preservation of biochemical liver function with low-dose soy-based lipids in children with intestinal failure-associated liver disease.
Khan FA; Fisher JG; Sparks EA; Potemkin A; Duggan C; Raphael BP; Modi BP; Jaksic T
J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):375-7. PubMed ID: 25714580
[TBL] [Abstract][Full Text] [Related]
32. Intravenous lipid emulsions in pediatric patients with intestinal failure.
Goulet O; Lambe C
Curr Opin Organ Transplant; 2017 Apr; 22(2):142-148. PubMed ID: 28267037
[TBL] [Abstract][Full Text] [Related]
33. Parenteral plant sterols and intestinal failure-associated liver disease in neonates.
Kurvinen A; Nissinen MJ; Andersson S; Korhonen P; Ruuska T; Taimisto M; Kalliomäki M; Lehtonen L; Sankilampi U; Arikoski P; Saarela T; Miettinen TA; Gylling H; Pakarinen MP
J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):803-11. PubMed ID: 22197940
[TBL] [Abstract][Full Text] [Related]
34. Intestinal failure-associated liver disease (IFALD): insights into pathogenesis and advances in management.
Lee WS; Chew KS; Ng RT; Kasmi KE; Sokol RJ
Hepatol Int; 2020 May; 14(3):305-316. PubMed ID: 32356227
[TBL] [Abstract][Full Text] [Related]
35. Lipid Emulsion Use in Pediatric Patients Requiring Long-Term Parenteral Nutrition.
Goulet OJ; Cai W; Seo JM
JPEN J Parenter Enteral Nutr; 2020 Feb; 44 Suppl 1():S55-S67. PubMed ID: 32049395
[TBL] [Abstract][Full Text] [Related]
36. Elimination of soybean lipid emulsion in parenteral nutrition and supplementation with enteral fish oil improve cholestasis in infants with short bowel syndrome.
Rollins MD; Scaife ER; Jackson WD; Meyers RL; Mulroy CW; Book LS
Nutr Clin Pract; 2010 Apr; 25(2):199-204. PubMed ID: 20413701
[TBL] [Abstract][Full Text] [Related]
37. Fish Oil Emulsion Reduces Liver Injury and Liver Transplantation in Children with Intestinal Failure-Associated Liver Disease: A Multicenter Integrated Study.
Gura KM; Premkumar MH; Calkins KL; Puder M
J Pediatr; 2021 Mar; 230():46-54.e2. PubMed ID: 33038344
[TBL] [Abstract][Full Text] [Related]
38. The impact of a lipid injectable emulsion (SMOF) on conjugated bilirubin levels in children receiving prolonged parenteral nutrition: A large single center experience.
Navaratnarajah N; Girard G; Sant'Anna G; Langlois H; Sant'Anna AM
Clin Nutr ESPEN; 2022 Jun; 49():289-294. PubMed ID: 35623828
[TBL] [Abstract][Full Text] [Related]
39. Liver Function in Pediatric Recipients: A Comparison of Intralipid and Smoflipid.
Daniel S; Svoboda L; Chen J
J Pediatr Pharmacol Ther; 2021; 26(3):258-264. PubMed ID: 33833627
[TBL] [Abstract][Full Text] [Related]
40. Hepatic dysfunction in patients receiving intravenous lipid emulsions.
Miles JM
Curr Opin Clin Nutr Metab Care; 2023 May; 26(3):278-283. PubMed ID: 36943142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
